In 2024, there will be 2 pharmaceutical enterprises in the province with the function of producing drugs (Hai Duong Medical Supply Pharmaceutical Joint Stock Company and FDA High-Tech Pharmaceutical Joint Stock Company).
In particular, FDA High-Tech Pharmaceutical Joint Stock Company has not been active in drug production since being granted a certificate of eligibility for drug production by the Ministry of Health. The total production value of pharmaceutical products of Hai Duong Medical Supply Pharmaceutical Joint Stock Company in 2024 is over 261 billion VND; The drug warehouses at the two above enterprises have all met the standards of "Good preservation practices" - GSP.
Currently, Hai Duong Medical supplies Pharmaceutical Joint Stock Company has 9 production lines meeting the "Good drug manufacturing practices" (GMP-WHO" standard, including 1 non- Bet Betalactam brand pharmaceutical manufacturing line certified by the Bulgaria Pharmaceutical Management Department with EU-GMP certification.
FDA High-Tech Pharmaceutical Joint Stock Company has 3 production lines meeting the "Good pharmaceutical manufacturing practices" (GMP-WHO) standard. The provision of drugs must ensure that there are all types of quality for the needs of disease prevention and treatment of the people and the prevention of epidemics, natural disasters and catastrophes.
According to reports from drug dealers in the province, the total value of drugs sold in 2024 is more than 758 billion. Hai Duong Medical Supply Pharmaceutical Joint Stock Company is the unit that plays a leading role in production and business (with more than 438 billion VND for drugs sold).
The Department of Health has coordinated with the Hai Duong Pharmaceutical Association to open a training course to update professional knowledge of pharmaceuticals for nearly 300 pharmacists; train current legal documents on pharmaceuticals, digital transformation for drug retail establishments for 90 participants; train current legal documents on pharmaceuticals, prescriptions, electronic prescriptions and digital transformation for drug retail establishments for 275 participants.
